HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobuhiro Yamanaka Selected Research

1-hexylindolactam-V10

1/2008Synthesis, conformational analysis, and biological evaluation of 1-hexylindolactam-V10 as a selective activator for novel protein kinase C isozymes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobuhiro Yamanaka Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
01/2008
1Neoplasms (Cancer)
01/2008
1Reperfusion Injury
01/2008

Drug/Important Bio-Agent (IBA)

11-hexylindolactam-V10IBA
01/2008
1IsoenzymesIBA
01/2008